Section 112(a) Enablement and Written Description Issues in Life Science Cases: Leveraging CCPA and Federal Circuit Decisions
September 29, 2020
Webinar
Strafford Publications
As part of the Strafford Publications’ webinar series, Finnegan partners Adriana Burgy, Tom Irving, and Steven O’Connor. will guide patent counsel on leveraging decisions by the PTAB, the CCPA, and the Federal Circuit regarding the application of Section 112 written description and enablement requirements in life science patent cases. The panel will examine lessons learned from these decisions and offer strategies to overcome challenges under Section 112(a). For more information, or to register, please see Strafford’s website.
Tags
claim amendments, Enablement (35 USC § 112), invalidity, inventorship, Patent Trial and Appeal Board (PTAB), patentability, patentable subject matter, specification, substitute claims, United States Court of Appeals for the Federal Circuit (CAFC), validity, Written description (35 USC § 112)
